Oct 8, 2026 08:30AM
Oct 8, 2026 08:30AM
Oct 5, 2026 04:05PM
Oct 5, 2026 04:05PM
Aug 5, 2026 04:05PM
May 18, 2026 04:05PM
May 18, 2026 04:05PM Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association for the Study of the Liver (EASL) Congress 2026
May 6, 2026 04:05PM
Apr 13, 2026 08:05AM
Apr 13, 2026 08:05AM
Feb 23, 2026 05:15PM
Feb 23, 2026 05:14PM
Feb 23, 2026 05:02PM
Feb 23, 2026 05:02PM Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
Jun 5, 2024 05:46AM
May 13, 2024 07:21PM
Jun 25, 2023 08:00AM
Mar 24, 2023 01:18AM
Jul 6, 2020 07:03AM
Jul 6, 2020 07:00AM
Jul 6, 2020 07:00AM Vir Biotechnology Announces Proposed Public Offering of Common Stock
Feb 27, 2020 09:23AM
Sep 30, 2019 06:13AM

68,863 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All